Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Underpinning Pathogenesis and Therapeutics

被引:24
|
作者
Dunleavy, Katie A. [1 ]
Raffals, Laura E. [1 ]
Camilleri, Michael [1 ,2 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Clin Enter Neurosci Translat & Epidemiol Res CENT, Rochester, MN USA
关键词
Intestinal permeability; Inflammatory bowel disease; Mucus; Tight junctions;
D O I
10.1007/s10620-023-08122-w
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The intestinal barrier is composed of several essential elements including luminal enzymes, bile acids, water layer, epithelial layer, and enterocyte layer. It acts as a dynamic interface between the luminal contents of food, commensal and pathogenic bacteria, and the gastrointestinal tract. The role of barrier dysfunction is of significant research interest in the development and targeted treatment of chronic inflammatory gastrointestinal conditions, such as inflammatory bowel disease. This review aims to examine the role of intestinal barrier dysfunction in the development of inflammatory bowel disease, the pathophysiology of increased barrier permeability in inflammatory bowel disease, and to explore potential treatment targets and clinical applications.
引用
收藏
页码:4306 / 4320
页数:15
相关论文
共 50 条
  • [21] Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
    Xochitl C Morgan
    Timothy L Tickle
    Harry Sokol
    Dirk Gevers
    Kathryn L Devaney
    Doyle V Ward
    Joshua A Reyes
    Samir A Shah
    Neal LeLeiko
    Scott B Snapper
    Athos Bousvaros
    Joshua Korzenik
    Bruce E Sands
    Ramnik J Xavier
    Curtis Huttenhower
    Genome Biology, 13
  • [22] Gut virome and its implications in the pathogenesis and therapeutics of inflammatory bowel disease
    Wu, Yushan
    Cheng, Rui
    Lin, Hao
    Li, Lili
    Jia, Yongbin
    Philips, Anna
    Zuo, Tao
    Zhang, Hu
    BMC MEDICINE, 2025, 23 (01):
  • [23] Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics
    Hering, Nina A.
    Fromm, Michael
    Schulzke, Joerg-Dieter
    JOURNAL OF PHYSIOLOGY-LONDON, 2012, 590 (05): : 1035 - 1044
  • [24] Functional Impacts of the Intestinal Microbiome in the Pathogenesis of Inflammatory Bowel Disease
    Li, Jennifer
    Butcher, James
    Mack, David
    Stintzi, Alain
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (01) : 139 - 153
  • [25] Microbial Sensing by the Intestinal Epithelium in the Pathogenesis of Inflammatory Bowel Disease
    Scharl, Michael
    Rogler, Gerhard
    INTERNATIONAL JOURNAL OF INFLAMMATION, 2010, 2010
  • [26] Evaluation the intestinal barrier function patients with inflammatory bowel disease
    Abdulganieva, D.
    Mukhametova, D.
    Koshkin, S.
    Zinkevich, O.
    Saphina, N.
    Abdulkhakov, S.
    Odintsova, A.
    Koporulina, M.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S84 - S85
  • [27] The intestinal complement system in inflammatory bowel disease: Shaping intestinal barrier function
    Sina, Christian
    Kemper, Claudia
    Derer, Stefanie
    SEMINARS IN IMMUNOLOGY, 2018, 37 (0C) : 66 - 73
  • [28] Role of miRNA in chronic inflammatory bowel disease pathogenesis and their potential in diagnostics and therapeutics
    Berthet, Louis
    Casado-Bedmar, Maite
    Viennois, Emilie
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2024, 208 (08): : 999 - 1007
  • [29] Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease
    Zi-Kai Wang
    Yun-Sheng Yang
    Ye Chen
    Jing Yuan
    Gang Sun
    Li-Hua Peng
    World Journal of Gastroenterology, 2014, (40) : 14805 - 14820
  • [30] Pathogenesis of Intestinal Fibrosis in Inflammatory Bowel Disease and Perspectives for Therapeutic Implication
    Bettenworth, Dominik
    Rieder, Florian
    DIGESTIVE DISEASES, 2017, 35 (1-2) : 25 - 31